Key Vendors in Biopolar Disorder Therapeutics Market in the Allergan, AstraZeneca, BMS, Eli Lilly, GSK and Janssen Pharmaceuticals Says a 2019 Report

The analyst forecast global biopolar disorder therapeutics market to grow at a CAGR of 2.24% over the period 2014-2019.

Biopolar disorder is a psychological disorder characterized by intermittent mood swings. The individual suffering with this disorder experiences extreme poles of either mania or depression or both. The disorder severely affects the personal, social, and professional life of an individual. The symptoms usually include drastic changes in mood, either as a manic episode or a depressive episode. There is no complete cure for the disorder. Atypical antipsychotics, mood stabilizers, and antidepressants are being widely used in for treatment. It is considered as a lifelong disease and the discontinuation of the medication can lead to relapse of the condition.

Covered in this report

The report covers the present scenario and growth prospects of the global bipolar disorder therapeutics market for 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used in the treatment of bipolar disorder.

The report, Global Biopolar Disorder Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, APAC, and EMEA; it also covers the landscape of the global bipolar disorder therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Purchase a copy of the report at .

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Allergan
  • AstraZeneca
  • BMS
  • Eli Lilly
  • GlaxoSmithKline
  • Janssen Pharmaceuticals

Other prominent vendors

  • AbbVie
  • Abital Pharma
  • Astellas
  • Convergence Pharmaceuticals
  • D Pharm
  • Delpor
  • Gedeon Richter
  • H. Lundbeck
  • Intra-Cellular Therapies
  • Novartis
  • Noven Pharmaceuticals
  • Omeros Corporation
  • Otsuka
  • Pfizer
  • PNBDevCo
  • Reviva Pharmaceuticals
  • SK Biopharmaceuticals
  • Sunovion Pharmaceutical

Key market driver

  • Increase in prevalence of bipolar disorder

Key market challenge

  • Use of alternative therapies

Key market trend

  • Rise in public awareness

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

For more Information on the report, inquire at .

About US:  is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.